Evidence map›Paper›PMID 39779217›Full record

Trial reportAlcohol, clinical & experimental research2025

Pregnenolone effects on parasympathetic response to stress and alcohol cue provocation in treatment-seeking individuals with alcohol use disorder.

Huaze Gao, Rajita Sinha, Stephanie Wemm, Verica Milivojevic

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Alcohol, clinical & experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Huaze GaoDepartment of Psychiatry, The Yale Stress Center, Yale University School of Medicine, New Haven, Connecticut, USA.
Rajita SinhaDepartment of Psychiatry, The Yale Stress Center, Yale University School of Medicine, New Haven, Connecticut, USA.
Stephanie WemmDepartment of Psychiatry, The Yale Stress Center, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0001-8754-7479
Verica MilivojevicDepartment of Psychiatry, The Yale Stress Center, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0001-6752-2223

Funding

Pregnenolone for the Treatment of Alcohol Use DisorderR01AA030923 · NIAAA · YALE UNIVERSITY · PI VERICA MILIVOJEVIC, Rajita Sinha · 2023 to 2026
$2.9M
Neuroactive Steroid Potentiation to Decrease Alcohol Craving, Normalize HPA axis function and Prevent Alcohol RelapseR01AA026514 · NIAAA · YALE UNIVERSITY · PI SINHA, RAJITA · 2018 to 2021
$2.8M
The role of neuroactive steroids in stress, drug craving and drug use in cocaine use disordersK01DA046561 · NIDA · YALE UNIVERSITY · PI MILIVOJEVIC, VERICA · 2019 to 2023
$913k
NIAAA NIH HHS R01 AA026514NIAAA NIH HHS R01-AA026514NIAAA NIH HHS R01 AA030923NIAAA NIH HHS R01-AA030923NIDA NIH HHS K01 DA046561NIDA NIH HHS K01-DA046561
6 · The paper itself

Abstract

backgroundChronic alcohol consumption in alcohol use disorder (AUD) is associated with autonomic nervous system dysregulation, increasing cardiovascular risk, and high alcohol cravings. Heart rate variability (HRV), a marker of autonomic nervous system responsiveness to stressors, may mediate alcohol's impact on the cardiovascular system. While pregnenolone (PREG) has been shown to normalize heart rate and blood pressure in individuals with AUD, its effects on sympathetic and parasympathetic components of HRV and related alcohol craving are not known.

methodsFifty-five treatment-seeking individuals with AUD were randomized to placebo (n = 21) or daily pregnenolone at 300 mg (n = 18) or 500 mg (n = 16), in a double-blind, 8-week pilot clinical trial. In week 2, participants underwent three randomized, counterbalanced 5-minute personalized guided imagery provocations (stress, alcohol, and neutral/relaxing cues) on separate days. HRV indices were assessed during each session and analyzed using linear mixed-effects models (LMEs), including association between HRV indices and anxiety and alcohol craving.

resultsA medication group × condition interaction was found for parasympathetic, high-frequency (HF) (p = 0.028) and sympathetic/parasympathetic, low-frequency/high-frequency (LF/HF) ratio (p = 0.017) indices of HRV. Placebo had higher HF during alcohol cue (p = 0.011), while 500 mg PREG demonstrated lower HF in response to stress (p = 0.050) and alcohol cues (p = 0.047). Placebo showed lower LF/HF ratio during stress (p = 0.006) and alcohol cue (p = 0.001), while the PREG groups showed no changes. Overall, the LF/HF response to alcohol cue was significantly lower in placebo compared to the 300 mg PREG (p = 0.012) and 500 mg PREG (p = 0.037) groups. Lastly, HF was found to predict alcohol craving regardless of PREG doses.

conclusionsWe found a normalization of autonomic response in PREG groups. These findings suggest that PREG holds therapeutic potential for enhancing autonomic function in AUD.

Indexed as

AlcoholismCuesParasympathetic Nervous SystemPregnenoloneStress, PsychologicalAdultCravingDouble-Blind MethodFemaleHeart RateHumansMaleMiddle AgedPilot ProjectsPregnenolonealcohol cuealcohol use disordersheart rate variabilitypregnenolonestress

Identifiers

PMID39779217
PMCPMC11928267

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.